Technology and health care in an era of limits
Author(s)
Bibliographic Information
Technology and health care in an era of limits
(Medical innovation at the crossroads, v. 3)
National Academy Press, 1992
Available at 8 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Papers presented at the third Institute of Medicine workshop "The Changing Health Care Economy," held April 18-19, 1991, supported by the Howard Hughes Medical Institute, Pfizer, Inc., and the Health Industry Manufacturers Association
Includes bibliographical references and index
Description and Table of Contents
Description
The U.S. health care system is in a state of flux, and changes currently under way seem capable of exerting sizable effects on medical innovation.
This volume explores how the rapid transition to managed care might affect the rate and direction of medical innovation. The experience with technological change in medicine in other nations whose health care systems have "single-payer" characteristics is thoroughly examined.
Technology and Health Care in an Era of Limits examines how financing and care delivery strategies affect the decisions made by hospital administrators and physicians to adopt medical technologies. It also considers the patient's stake in the changing health care economy and the need for a stronger independent contribution of patients to the choice of technology used in their care.
Finally, the volume explores the impact of changes in the demand for medical technology in pharmaceutical, medical device, and surgical procedure innovation.
Table of Contents
FRONT MATTER
PART I: SETTING THE STAGE
PART II: MANAGING CARE IN THE UNITED STATES
PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA
PART IV: IMPLICATIONS FOR PROVIDERS
PART V: IMPLICATIONS FOR PATIENTS
PART VI: IMPLICATIONS FOR INNOVATORS
PART VII: CONCLUDING OBSERVATIONS
APPENDIXES
INDEX
Table of Contents
- 1 FRONT MATTER
- 2 PART I: SETTING THE STAGE
- 3 PART II: MANAGING CARE IN THE UNITED STATES
- 4 PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA
- 5 PART IV: IMPLICATIONS FOR PROVIDERS
- 6 PART V: IMPLICATIONS FOR PATIENTS
- 7 PART VI: IMPLICATIONS FOR INNOVATORS
- 8 PART VII: CONCLUDING OBSERVATIONS
- 9 APPENDIXES
- 10 INDEX
by "Nielsen BookData"